News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 445
- Sources here
- 21
- Companies here
- 11
Search results
Stored financial headlines
Active search
445 matching headlines
Ticker or company: AARMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AAR CORP (NYSE: AIR) VP reports 3,979-share tax withholding event
Eric Pachapa, VP-CAO & Controller of AAR CORP (NYSE: AIR), reported two tax-withholding dispositions on July 31, 2026, totaling 3,979 shares of common stock. These shares, valued at $140.04 each, were withheld to cover tax obligations related to the vesting of both performance-based and …
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
AAR Corp. $AIR Shares Sold by Royal Bank of Canada
Royal Bank of Canada reduced its stake in AAR Corp. (NYSE:AIR) by 7.4% in the first quarter, selling 36,724 shares but still owning 460,344 shares valued at over $50 million. Despite this, institutional investors collectively hold 90.74% of the company, and AAR maintains a …
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
How (STAA) Movements Inform Risk Allocation Models
This article analyzes Staar Surgical Company (NASDAQ: STAA) movements, highlighting weak near and mid-term sentiment, but a neutral long-term outlook. It presents AI-generated institutional trading strategies for various risk profiles, including position trading, momentum breakout, and risk hedging. The analysis also provides multi-timeframe signal …
STAA
main company
Sharemaestro market context
Trend signal active
52 weeks -6.0% · Next-week setup negative 40.7%
AARD|Aardvark Therapeutics Inc|Price:6.600|Chg%:+0.200
This article provides a detailed financial overview of Aardvark Therapeutics Inc (AARD), including real-time quotes, key financial figures, and market trends. It highlights the company's current stock performance, analyst ratings indicating a "Buy" with a target price of $14.00, and a company overview focusing …
AARD
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.1%
AAR (NYSE:AIR) Downgraded to "Hold" Rating by Wall Street Zen
Wall Street Zen has downgraded AAR (NYSE:AIR) from "Buy" to "Hold," despite the broader analyst consensus remaining a "Moderate Buy" with a $135.60 price target. This downgrade occurred after AAR reported strong quarterly earnings, beating EPS and revenue estimates, and with its shares opening …
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
First Trust Advisors LP Increases Stock Holdings in AAR Corp. $AIR
First Trust Advisors LP increased its holdings in AAR Corp. by 20.4% in the first quarter, now owning 90,749 shares valued at $9.9 million. This aerospace company recently reported strong quarterly earnings, beating consensus estimates with $1.53 EPS and $928 million in revenue, a …
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
AAR Number of Employees 2026 | Employee Count & Headcount Data
As of March 2026, AAR Corp. (AIR) has approximately 5,662 employees worldwide, representing a 3.3% growth since 2023 but a 0.5% decline year-over-year. The company is actively hiring, with 552 job postings in 2026, though this is a 24.8% decrease from 2025. AAR's workforce …
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
AAR Corp (AIR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of AAR Corp (AIR), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that the stock is currently trading between a resistance level of 148.56 and a support level of 127.06, making …
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
RBC Capital Maintains AAR Corp(AIR.US) With Buy Rating, Raises Target Price to $286.35
RBC Capital has reiterated its Buy rating on AAR Corp (AIR.US) and increased the price target to $286.35. This indicates a continued positive outlook on the company's stock performance.
AIR
main company
Sharemaestro market context
Trend signal active
52 weeks +91.6%
Aardvark shares plunge 32% after FDA halts clinical trial for Prader-Willi Syndrome drug.
Aardvark Therapeutics' stock dropped 32% after the FDA placed a clinical hold on its Prader-Willi Syndrome drug, ARD-101, due to serious safety concerns, following a previous 56% decline when its Phase 3 trial was halted for similar reasons. An investigation has been launched into …
AARD
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.1%
Aardvark Therapeutics (AARD) Scrutinized Again After FDA Hold on Lead Drug Candidate, May Announcement Drives Stock 32% Lower - Hagens Berman
Hagens Berman is continuing its investigation into Aardvark Therapeutics (AARD) after the FDA placed a clinical hold on its lead drug candidate, ARD-101, for Prader-Willi Syndrome. This follows a previous 56% stock drop when Aardvark paused its HERO trial due to serious safety risks, …
AARD
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.1%
Aardvark Therapeutics Market Sentiment
This article analyzes market sentiment for Aardvark Therapeutics (AARD) based on analyst consensus, short interest, options flow, and recent insider activity. Key signals show a "Buy" consensus from analysts, 3.7% short interest, and a 0.00 Put/Call ratio indicating more bullish calls. The article provides …
AARD
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.1%